Juventix Regenerative Medical

Juventix Regenerative Medical, LLC is a leader in regenerative medicine, focusing on FDA-cleared Platelet-Rich Plasma (PRP) therapy products and related cell therapy technologies. Founded over a decade ago by Lance Liberti, the company provides non-surgical solutions that enhance patient outcomes in various medical fields, including aesthetics, orthopedics, neurology, and sports medicine. The company offers advanced PRP kits designed for reliability and safety, featuring a closed-cycle, sterile system that maximizes platelet recovery. These kits support treatments for pain management, cosmetic rejuvenation, and hair restoration. Juventix also provides specialized devices like LED photoactivation units and centrifuges to ensure optimal PRP preparation. Additionally, they offer comprehensive training workshops and resources to help practitioners integrate their products into healthcare practices seamlessly. In 2025, Juventix expanded its offerings through a partnership with Juvasonic®, introducing a needle-free delivery device that enhances the absorption of PRP and other biologics. With a commitment to safety and quality, Juventix's products are FDA-cleared and certified under ISO 13485 and CE standards, ensuring effective and patient-centered regenerative therapies.

• Employees 32
• Founded 2017
• Annual Revenue $2000000